NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗凝血劑的全球市場(2020年∼2024年)

Global Anticoagulants Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 974982
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
抗凝血劑的全球市場(2020年∼2024年) Global Anticoagulants Market 2020-2024
出版日期: 2020年12月01日內容資訊: 英文 120 Pages
簡介

抗凝血劑的市場規模在2020年∼2024年的預測期間內,預計將以8%的年複合成長率增長,並成長到136億1,000萬美元。

新型口服抗凝劑的引入,血液凝塊疾病的流行以及髖關節和膝關節外科手術的增加推動了市場的發展。特別是新型口服抗凝劑的引入有望促進市場增長。

這份報告提供抗凝血劑的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,應用·給藥途徑·類型·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模(2019年)
  • 市場預測(2019年∼2024年)

波特的五力分析

各應用領域

  • DVT
  • PE
  • AF
  • 其他

各給藥途徑

  • 口服
  • 注射

各類型

  • 市場區隔
  • 各類型比較
  • 凝血因子Xa抑制劑
  • DTI
  • 肝素
  • 維他命K拮抗劑
  • 各類型的市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 市場區隔
  • 各地區比較
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

附錄

目錄
Product Code: IRTNTR45642

Technavio has been monitoring the anticoagulants market and it is poised to grow by $ 13.61 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our report on the anticoagulants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of novel oral anticoagulants, the growing prevalence of coagulation disorders and an increase in hip and knee surgeries. In addition, the introduction of novel oral anticoagulants is anticipated to boost the growth of the market as well.

The anticoagulants market analysis includes the type segment and geographical landscapes.

Technavio's anticoagulants market is segmented as below:

By Type

  • Factor Xa inhibitors
  • DTIs
  • Heparin
  • Vitamin K antagonists

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the advent of anticoagulant antidotes as one of the prime reasons driving the anticoagulants market growth during the next few years. Also, patient assistance programs and increasing focus toward emerging economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anticoagulants market covers the following areas:

  • Anticoagulants market sizing
  • Anticoagulants market forecast
  • Anticoagulants market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anticoagulants market vendors that include Abbott Laboratories, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi. Also, the anticoagulants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • DVT
  • PE
  • AF
  • Others

Market Segmentation by Route of Administration

  • Oral anticoagulants
  • Injectable anticoagulants

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Factor Xa inhibitors - Market size and forecast 2019-2024
  • DTIs - Market size and forecast 2019-2024
  • Heparin - Market size and forecast 2019-2024
  • Vitamin K antagonists - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Type - Market share 2019-2024 (%)
  • 22: Comparison by Type
  • 23: Factor Xa inhibitors - Market size and forecast 2019-2024 ($ million)
  • 24: Factor Xa inhibitors - Year-over-year growth 2019-2024 (%)
  • 25: DTIs - Market size and forecast 2019-2024 ($ million)
  • 26: DTIs - Year-over-year growth 2019-2024 (%)
  • 27: Heparin - Market size and forecast 2019-2024 ($ million)
  • 28: Heparin - Year-over-year growth 2019-2024 (%)
  • 29: Vitamin K antagonists - Market size and forecast 2019-2024 ($ million)
  • 30: Vitamin K antagonists - Year-over-year growth 2019-2024 (%)
  • 31: Market opportunity by Type
  • 32: Customer landscape
  • 33: Market share by geography 2019-2024 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2019-2024 ($ million)
  • 36: North America - Year-over-year growth 2019-2024 (%)
  • 37: Europe - Market size and forecast 2019-2024 ($ million)
  • 38: Europe - Year-over-year growth 2019-2024 (%)
  • 39: Asia - Market size and forecast 2019-2024 ($ million)
  • 40: Asia - Year-over-year growth 2019-2024 (%)
  • 41: ROW - Market size and forecast 2019-2024 ($ million)
  • 42: ROW - Year-over-year growth 2019-2024 (%)
  • 43: Key leading countries
  • 44: Market opportunity by geography ($ million)
  • 45: Impact of drivers and challenges
  • 46: Vendor landscape
  • 47: Landscape disruption
  • 48: Industry risks
  • 49: Vendors covered
  • 50: Market positioning of vendors
  • 51: Abbott Laboratories - Overview
  • 52: Abbott Laboratories - Business segments
  • 53: Abbott Laboratories - Key offerings
  • 54: Abbott Laboratories - Key customers
  • 55: Abbott Laboratories - Segment focus
  • 56: AstraZeneca Plc - Overview
  • 57: AstraZeneca Plc - Product and service
  • 58: AstraZeneca Plc - Key offerings
  • 59: AstraZeneca Plc - Key customers
  • 60: AstraZeneca Plc - Segment focus
  • 61: Bayer AG - Overview
  • 62: Bayer AG - Business segments
  • 63: Bayer AG - Key offerings
  • 64: Bayer AG - Key customers
  • 65: Bayer AG - Segment focus
  • 66: Boehringer Ingelheim International GmbH - Overview
  • 67: Boehringer Ingelheim International GmbH - Business segments
  • 68: Boehringer Ingelheim International GmbH - Key offerings
  • 69: Boehringer Ingelheim International GmbH - Key customers
  • 70: Boehringer Ingelheim International GmbH - Segment focus
  • 71: Bristol-Myers Squibb Co. - Overview
  • 72: Bristol-Myers Squibb Co. - Product and service
  • 73: Bristol-Myers Squibb Co. - Key offerings
  • 74: Bristol-Myers Squibb Co. - Key customers
  • 75: Bristol-Myers Squibb Co. - Segment focus
  • 76: Daiichi Sankyo Co. Ltd. - Overview
  • 77: Daiichi Sankyo Co. Ltd. - Business segments
  • 78: Daiichi Sankyo Co. Ltd. - Key offerings
  • 79: Daiichi Sankyo Co. Ltd. - Key customers
  • 80: Daiichi Sankyo Co. Ltd. - Segment focus
  • 81: Johnson & Johnson - Overview
  • 82: Johnson & Johnson - Business segments
  • 83: Johnson & Johnson - Key offerings
  • 84: Johnson & Johnson - Key customers
  • 85: Johnson & Johnson - Segment focus
  • 86: Novartis AG - Overview
  • 87: Novartis AG - Business segments
  • 88: Novartis AG - Key offerings
  • 89: Novartis AG - Key customers
  • 90: Novartis AG - Segment focus
  • 91: Pfizer Inc. - Overview
  • 92: Pfizer Inc. - Business segments
  • 93: Pfizer Inc. - Key offerings
  • 94: Pfizer Inc. - Key customers
  • 95: Pfizer Inc. - Segment focus
  • 96: Sanofi - Overview
  • 97: Sanofi - Business segments
  • 98: Sanofi - Key offerings
  • 99: Sanofi - Key customers
  • 100: Sanofi - Segment focus
  • 101: Currency conversion rates for US$
  • 102: Research Methodology
  • 103: Validation techniques employed for market sizing
  • 104: Information sources
  • 105: List of abbreviations